Angelini Chemicals
-
-
Since 1967 into API CDMO business
-
We help to make your Molecules
-
Put your chemistry in our hands
News & publications
-
Pubblicato:
HIGH-POTENT API: Strategy and Legacy
The pharmaceutical landscape is continuously evolving, driven by innovation in drug development and the growing demand for targeted therapies. High-potency active pharmaceutical ingredients (HPAPIs) have emerged as crucial components in treating diseases such as cancer and autoimmune disorders. Recognizing the increasing importance of HPAPIs, our company has strategically diversified into their production, and our extensive experience in producing traditional APIs provides a foundation for success in this new venture.
-
Pubblicato:
Biotech Outsourcing Strategies
BOS Basel 2026's scope is primarily development stage CMC outsourcing for both Small Molecules and Biologics, as well as covering Novel Therapeutic Entities.
-
Pubblicato:
CPHI Europe 2026
CPHI Milan is the most important pharmaceutical event worldwide and represents each stage of the pharmaceutical supply chain.